Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dahuang Tongbian Capsules is a traditional Chinese medicine (TCM) product manufactured by Sichuan Defeit Pharmaceutical, primarily used as a stimulant laxative for the treatment of constipation. The formulation is based on *Dahuang* (Rhubarb), which contains active anthraquinone glycosides such as emodin, rhein, and chrysophanol. These compounds are metabolized by intestinal flora into active anthrones that stimulate the colonic mucosa, increasing peristalsis and altering electrolyte transport to promote water secretion into the intestinal lumen. This dual action facilitates bowel movement and relieves symptoms of heat-accumulation constipation, a common diagnosis in TCM. The product is currently marketed in China as an approved pharmaceutical for oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dahuang Tongbian Capsules.